Lv1
100 积分 2024-10-24 加入
New-generation antibiotics and nonantibiotic strategies against carbapenemase-producing Enterobacterales: More focus on metallo-β-lactamase producers
2个月前
已完结
Efficacy and safety of cefepime–nacubactam and aztreonam–nacubactam compared with imipenem–cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial
2个月前
已完结
Antibiotics and non-traditional antimicrobial agents for carbapenem-resistant Acinetobacter baumannii in Phase 1, 2, and 3 clinical trials
2个月前
已完结
The efficacy and safety of inhaled antibiotics in the treatment of lower respiratory tract infection: An updated meta-analysis and evidence map of systematic reviews
3个月前
已完结
Interconnected reservoirs and escalating resistance in multidrug-resistant Pseudomonas aeruginosa: An One Health review
3个月前
已关闭
New report assesses antimicrobial pipeline
3个月前
已关闭
The Emerging Resistance Index: tracking early resistance to new antibiotics
3个月前
已完结
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype
3个月前
已完结
临床研究的选题设计
4个月前
已完结
Effects of a Novel Dual Phosphodiesterase 3 and 4 Inhibitor TQC3721 inPatients with COPD in China (PACER-II): a phase 2, multicentre, randomised,double-blind, placebo-controlled trial
4个月前
已关闭
皖公网安备34019202002308
